Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MRVI · against 1,336 other Healthcare companies
Ranked #953 of 1,337 · scores higher than 8% of peers
Bars: peers in each 10-point band of the valuation score385 peers with a valuation score of 0–9, including MRVI · Click a bar to see the companies
Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
| Metric | MRVI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -7.1% | 1.5% | 23% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | -1.4% | 4.2% | 28% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -1.3% | -1.0% | 49% | 20% | |
| Book yieldHigher is better · 1,306 reported | 18.4% | 37.9% | 26% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 953 | 996M USD | 8 | 35 | |
| 953 | 1.4B USD | 8 | 39 | |
| 953 | 100M CHF (≈$115M) | 8 | ||
| 953 | 91.2B USD | 8 | 18 | |
| 953 | 2.8B USD | 8 | 22 | |
| 953 | 578M USD | 8 | 22 | |
| 953 | 2.3B USD | 8 | 26 | |
| 953 | 68M EUR (≈$75M) | 8 | 34 | |
| 953 | 299M USD | 8 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score